ABOS
Acumen Pharmaceuticals Inc

1,273
Mkt Cap
$190.2M
Volume
361,342.00
52W High
$3.41
52W Low
$0.8551
PE Ratio
-1.42
ABOS Fundamentals
Price
$3.36
Prev Close
$3.14
Open
$3.15
50D MA
$2.41
Beta
1.59
Avg. Volume
354,555.27
EPS (Annual)
-$1.71
P/B
2.04
Rev/Employee
$0.00
$38.63
Loading...
Loading...
News
all
press releases
Acumen Pharmaceuticals (NASDAQ:ABOS) Upgraded at Wall Street Zen
Wall Street Zen upgraded Acumen Pharmaceuticals from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·18d ago
News Placeholder
More News
News Placeholder
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Sees Significant Increase in Short Interest
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS - Get Free Report) was the recipient of a significant increase in short interest during the month of January. As of January 30th, there was short interest...
MarketBeat·25d ago
News Placeholder
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Given Average Rating of "Moderate Buy" by Brokerages
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the six ratings firms that are currently covering the company...
MarketBeat·1mo ago
News Placeholder
Acumen Pharmaceuticals (NASDAQ:ABOS) Rating Lowered to Sell at Wall Street Zen
Wall Street Zen downgraded shares of Acumen Pharmaceuticals from a "hold" rating to a "sell" rating in a research report on Saturday...
MarketBeat·1mo ago
News Placeholder
Acumen Pharmaceuticals (NASDAQ:ABOS) Price Target Raised to $7.00 at BTIG Research
BTIG Research boosted their price objective on shares of Acumen Pharmaceuticals from $4.00 to $7.00 and gave the company a "buy" rating in a research note on Tuesday...
MarketBeat·1mo ago
News Placeholder
Acumen Pharmaceuticals (NASDAQ:ABOS) CFO Sells $12,536.16 in Stock
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS - Get Free Report) CFO Matt Zuga sold 6,888 shares of the stock in a transaction dated Thursday, January 8th. The shares were sold at an average price of...
MarketBeat·2mo ago
News Placeholder
Insider Selling: Acumen Pharmaceuticals (NASDAQ:ABOS) CFO Sells 6,888 Shares of Stock
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS - Get Free Report) CFO Matt Zuga sold 6,888 shares of Acumen Pharmaceuticals stock in a transaction dated Thursday, January 8th. The shares were sold at an...
MarketBeat·2mo ago
News Placeholder
Acumen Pharmaceuticals (NASDAQ:ABOS) CEO Sells $14,820.26 in Stock
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS - Get Free Report) CEO Daniel Joseph Oconnell sold 8,143 shares of the stock in a transaction on Thursday, January 8th. The shares were sold at an average...
MarketBeat·2mo ago
News Placeholder
Acumen Pharmaceuticals (NASDAQ:ABOS) CEO Daniel Joseph Oconnell Sells 12,941 Shares
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS - Get Free Report) CEO Daniel Joseph Oconnell sold 12,941 shares of the business's stock in a transaction that occurred on Friday, January 9th. The stock was...
MarketBeat·2mo ago
News Placeholder
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Receives Average Rating of "Moderate Buy" from Brokerages
Shares of Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS - Get Free Report) have earned an average rating of "Moderate Buy" from the five research firms that are presently covering the company...
MarketBeat·2mo ago
<
1
2
...
>

Latest ABOS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.